Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PMC-309 |
Trade Name | |
Synonyms | PMC309|PMC 309 |
Drug Descriptions |
PMC-309 is an antibody targeting VSIR (VISTA), which potentially induces antitumor immune activity (Cancer Res (2022) 82 (12_Supplement): 5557). |
DrugClasses | VSIR Antibody 6 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + PMC-309 | PMC-309 Pembrolizumab | 0 | 1 |
PMC-309 | PMC-309 | 0 | 1 |